ARTICLE | Clinical News
Isis preclinical data
September 20, 2004 7:00 AM UTC
ISIS 345794 reduced STAT3 mRNA levels up to 95% and showed antitumor activity in multiple human xenograft models of cancer. ISIS expects the compound to enter the clinic in 2005. Data were presented ...